Reframing the Future of Early Detection: Navigating Complexities of Imaging-Based Cancer Screening скачать в хорошем качестве

Reframing the Future of Early Detection: Navigating Complexities of Imaging-Based Cancer Screening

Reframing the Future of Early Detection: Navigating the Complexities of Imaging-Based Cancer Screening Imaging-based cancer screening remains one of radiology's most consequential contributions to public health. In "Current Challenges in Imaging-Based Cancer Screening", Grimm et al. provide a comprehensive, multispecialty analysis of the evolving evidence, controversies, and policy implications surrounding screening for lung, breast, colorectal, prostate, and hepatocellular carcinoma. The authors emphasize that while early detection reduces cancer-specific mortality and treatment morbidity, screening is inherently a balance of benefit and harm. Overdiagnosis, overtreatment, false-positive examinations, radiation exposure, psychologic burden, and financial costs must be weighed against mortality reduction. Importantly, mortality—not survival—is underscored as the appropriate endpoint due to lead-time bias. The review highlights methodological tensions in guideline development. Although randomized controlled trials (RCTs) remain the evidentiary gold standard, many pivotal trials are decades old and reflect outdated technologies. Contemporary policy increasingly relies on observational and modeling studies (e.g., CISNET), each vulnerable to bias, calibration limitations, and structural assumptions. Disease-specific challenges are thoughtfully examined. In lung cancer screening, LDCT reduces mortality but raises concerns regarding indolent ground-glass nodules and real-world overdiagnosis. Breast cancer screening faces ongoing debate surrounding ductal carcinoma in situ (DCIS) and active surveillance strategies. CT colonography offers competitive sensitivity with distinct trade-offs in radiation and extracolonic findings. Prostate cancer screening increasingly integrates MRI to mitigate PSA-driven overdiagnosis. HCC surveillance balances ultrasound accessibility against limited sensitivity, prompting growing interest in multiphasic CT, MRI, and biomarker refinement. Across modalities, emerging themes include risk-adapted screening, supplemental imaging, AI-assisted detection and risk stratification, and the necessity of radiologist leadership in evidence-based policy formation. As imaging technologies advance, screening algorithms must dynamically evolve to preserve net population benefit. Radiologists are not merely interpreters—they are stewards of screening strategy, responsible for aligning technological innovation with ethical, data-driven patient care. APA (7th edition) Citation Grimm, L. J., Kruse, D. E., Tailor, T. D., Johnson, K. S., Allen, B. C., & Ryser, M. D. (2026). Current challenges in imaging-based cancer screening: From the AJR Special Series on Screening. American Journal of Roentgenology, 226. Hashtags #CancerScreening #Overdiagnosis #EarlyDetection #Overtreatment #PreventiveMedicine #MedicalImaging #Radiology #PopulationHealth #AIinMedicine #LungCancer #BreastImaging #ColorectalCancer #ProstateMRI #HCC #EvidenceBasedMedicine © 2025 AI Chavelle™ by Jeffrey Chen / SmartRad AI. All rights reserved.